Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14468-90-7

Post Buying Request

14468-90-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14468-90-7 Usage

Chemical Properties

Colourless Liquid

Uses

1-Trimethylsilyl-2-pyrrolidinone, is used as a fine chemical intermediate.

General Description

1-(Trimethylsilyl)-2-pyrrolidinone has been prepared by refluxing a mixture of 2-pyrrolidinone, triethylamine and trimethylchlorosilane in benzene. It undergoes sulfenylation with phenyl disulfide to form the corresponding bissulfide as the major product.

Check Digit Verification of cas no

The CAS Registry Mumber 14468-90-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,4,6 and 8 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 14468-90:
(7*1)+(6*4)+(5*4)+(4*6)+(3*8)+(2*9)+(1*0)=117
117 % 10 = 7
So 14468-90-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NOSi/c1-10(2,3)8-6-4-5-7(8)9/h4-6H2,1-3H3

14468-90-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L02638)  1-Trimethylsilyl-2-pyrrolidinone, 96%   

  • 14468-90-7

  • 10g

  • 518.0CNY

  • Detail
  • Alfa Aesar

  • (L02638)  1-Trimethylsilyl-2-pyrrolidinone, 96%   

  • 14468-90-7

  • 50g

  • 1729.0CNY

  • Detail
  • Aldrich

  • (461075)  1-(Trimethylsilyl)-2-pyrrolidinone  96%

  • 14468-90-7

  • 461075-10ML

  • 673.92CNY

  • Detail

14468-90-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-trimethylsilylpyrrolidin-2-one

1.2 Other means of identification

Product number -
Other names trimethylsilylpyrrolidone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14468-90-7 SDS

14468-90-7Relevant articles and documents

Studies toward gymnodimine: development of a single-pot Hua reaction for the synthesis of highly hindered cyclic imines.

Ahn,Cardenas,Yang,Romo

, p. 751 - 754 (2001)

[structure: see text]. In studies directed toward gymnodimine and related marine toxins, a single-pot variation of the Hua cyclic imine synthesis has been developed. The reaction involves generation of N-trimethylsilyl lactams in situ followed by alkyllithium addition leading directly to cyclic imines. Importantly, this reaction proceeds efficiently with highly hindered alpha,alpha-dialkyl lactams, provided 1,2-dimethoxyethane (DME) is used as solvent, leading to stable cyclic imines. Overall, this transformation allows a one-pot coupling of an alkyliodide and a lactam to give a cyclic imine.

Lactamomethylsilanes – Synthesis, Structures, and Reactivity towards CO2 and Phenylisocyanate

Herbig, Marcus,B?hme, Uwe,Kroke, Edwin

, p. 377 - 387 (2019)

Lactamomethylsilanes of γ-butyrolactam, δ-valerolactam, ε-caprolactam, and 1-isoindolinone (phthalimidine) with up to three methyl moieties were synthesized according to the chemical formula MexSiLac(4–x) (x = 0, 1, 2, and 3). Using the lactams as starting materials four synthetic routes were tested: salt elimination, transsilylation, transamination, and metallation of the lactames followed by reaction with methylchlorosilanes. All products were analyzed by NMR (1H, 13C and 29Si) and RAMAN spectroscopy. Selected solid products were crystallized and the molecular structure was determined by single-crystal X-ray diffraction. The reactivity of the lactamomethylsilanes towards phenylisocyanate and CO2 was studied.

A double alkylation - Ring closing metathesis approach to spiroimines

Brimble, Margaret A.,Trzoss, Michael

, p. 5613 - 5622 (2004)

As part of a programme directed towards the synthesis of the marine toxins, the spirolides and gymnodimine, a convenient synthesis of the key bicyclic spiroimine ring systems has been developed. The method involves double alkylation of a simple lactam, Grubbs ring closing metathesis of the resultant dialkylated lactam then reduction of the lactam to an imine.

Strong influence of intramolecular Si?O proximity on reactivity: Systematic molecular structure, solvolysis, and mechanistic study of cyclic N-trimethylsilyl carboxamide derivatives

Szalay, Roland,Harmat, Veronika,E?ri, János,Pongor, Gábor

supporting information, p. 2186 - 2192 (2017/05/16)

A comparative alcoholysis study of N-silylated derivatives of simple heterocyclic carboxamides (lactams, imides, ureas) is presented. The second-order rate constant values span a range as wide as three orders of magnitude. On the basis of DFT calculations, a good correlation between reactivity and the Si?O distance was found within each family of compounds. The viability of two different reaction pathways was evaluated using a detailed computational mechanistic study of the methanolysis of cyclic urea homologues. Peculiarities in the single-crystal X-ray diffraction structures of the trimethylsilyl and trimethylsiloxy phthalimides are also discussed.

COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF

-

Page/Page column 140, (2011/07/07)

Provided herein are compounds and methods of synthesis thereof. The compounds set forth herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders, neurodegenerative disorders, neuropsychiatric disorders, disorders of cognition, learning or memory, gastrointestinal disorders, lower urinary tract disorder, and cancer. Compounds set forth herein modulate the activity of metabotropic glutamate receptor 5 (mGluR5) in the central nervous system or the periphery. Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14468-90-7